STEVEN G. BRODIE
CIK 1640522 · VP - Pharma Operations · last filed 2018-10-24
STEVEN G. BRODIE is a VP - Pharma Operations who has filed 11 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing shows the insider exercised options covering $46.0K of NEO on Oct 24, 2018. Across all open-market trades the lifetime net is −$264.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $512.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$512.4K
1
11
-$264.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEO | VP - Pharma Operations | 45,953 | $11.15 | $512.4K | -$264.3K | 11 | 2018-10-24 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-24 | NEO | Exer (M) | +13,334 | $46.0K | EDGAR |
| 2018-02-28 | NEO | Grant (A) | — | $0 | EDGAR |
| 2017-07-06 | NEO | Mixed | +6,666 | $23.0K | EDGAR |
| 2017-05-02 | NEO | Grant (A) | — | $0 | EDGAR |
| 2017-03-28 | NEO | Exer (X) | +10,000 | $37.6K | EDGAR |
| 2017-03-22 | NEO | Sell (S) | −50,000 | -$396.7K | EDGAR |
| 2017-03-17 | NEO | Sell (S) | +16,550 | $132.4K | EDGAR |
| 2016-12-07 | NEO | Mixed | +10,000 | $16.9K | EDGAR |
| 2016-05-03 | NEO | Grant (A) | — | $0 | EDGAR |
| 2016-03-14 | NEO | Mixed | +50,000 | $74.0K | EDGAR |